Die Pressemitteilungen werden von der FUJIFILM Corporation in Japan herausgegeben.
Fujifilm kann nicht versichern, dass die von diesen Mitteilungen betroffenen Artikel in allen Ländern und Teilen dieser Welt käuflich erwerbbar sind.
Bitte beachten Sie, dass der Inhalt dieser Website zum Zeitpunkt der Pressemitteilung als solcher Gültigkeit hat und ohne vorherige Ankündigung geändert werden kann. Die in der jeweiligen Mitteilung veröffentlichten Informationen, einschließlich der Verfügbarkeit von Artikeln, Spezifikationen, Preise und Kontakte, sind die zum Zeitpunkt der Veröffentlichung geltenden.
- Jan 6, 2023
- FUJIFILM Cellular Dynamics Announces License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies
- Dez 13, 2022
- Fujifilm to Build an Advanced Semiconductor Materials Manufacturing Facility in South Korea
- Nov 22, 2022
- Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
- Okt 19, 2022
- Fujifilm develops “FUJINON HZK25-1000mm”
- Okt 6, 2022
- Fujifilm to establish its first Bio-CDMO site in Japan
- Okt 3, 2022
- Fujifilm to establish a local subsidiary in South Korea to accelerate business growth of cell culture media
- Sep 8, 2022
- Fujifilm announces a strategic investment in a new production facility in Kumamoto Japan to support the fast-growing semiconductor industry
- Jul 6, 2022
- Fujifilm launches FUJIFILM PROJECTOR Z6000
- Jul 1, 2022
- Fujifilm launches world’s first mobile app “FUJIFILM Prescale Mobile” that quantifies pressure based on color development on pressure measurement film
- Jun 30, 2022
- Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
- Jun 8, 2022
- Fujifilm Acquires European Inkjet System Integrator UNIGRAPHICA to Expand Inkjet Integration Business Globally
- Apr 5, 2022
- Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Mär 29, 2022
- Fujifilm Completes Acquisition of Shenandoah Biotechnology
- Mär 28, 2022
- Fujifilm Invests in a new manufacturing facility for inkjet pigment dispersions in the U.S.
- Mär 23, 2022
- Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
- Jan 26, 2022
- Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Dez 8, 2021
- Fujifilm Kicks Off Operations at its New, State-of-the-Art Cell Culture Media Manufacturing Facility in Europe
- Dez 1, 2021
- FUJIFILM Irvine Scientific Establishes a Bioprocessing Innovation and Collaboration Center in China (FUJIFILM Irvine Scientific)
- Okt 20, 2021
- Fujifilm launches 4K-compatible broadcast lens with 107× zoom “FUJINON UA107x8.4BESM”
- Sep 30, 2021
- Fujifilm agrees on core terms with Australian regenerative medicine venture Cynata to manufacture Cynata’s iPS cell-derived regenerative medicine products